European billionaires have benefited from the recent profits, in light of the region’s top performance stock markets this year, as they did about a billion dollars during a rare buying wave for their shares listed on stock exchanges. At the end of May, the founder of ‘Spotfai Technology’, Martin Lorentzon, filed a request to sell a million shares in the huge sound broadcasting business worth $ 660 million, which is the largest number of shares it immediately sold, as the company, which is based in Stockholm, is on the Stockholm, is. Similarly, Spanish Maria del Pino, a family member who established ‘Ferrovial’ on May 27, declared his share in the infrastructure business with the largest percentage in at least nine years and sold shares worth $ 271 million ($ 310 million) in the company established by her father. The twins Thomas and Andreas Streanmann have also filed a request since May 28 to sell shares of more than $ 100 million at Bio Tech (Biontech), in the first agreement sold their shares in the Kofid vaccine manufacturer, which is based in their homeland this year. European stocks perform in performance. The four have another majority share in each of the businesses after selling shares, and their total net wealth is about $ 49 billion, according to the Bloomberg index for billionaires. European stocks have emerged worldwide among the winners in the light of improving the continent’s economic expectations, while the trade war launched by President Donald Trump has disappeared the financial markets in the United States. The European “Stoxx 600” index performed better than the “S&B” index with a record 18 percentage points in dollars from the beginning of the year to Monday, driven by Germany’s historic spending and the height of the euro. European businesses represented 7 out of ten best performance companies during 2025 on the Global MSCI index. The shares of “Spotfai” and “ferofial” have also risen to record levels in recent weeks, while “Bio Tech” has risen about 14% this month after the “Bristol Maires Squid” announced on June 2 that it would pay to the immune therapy business – which in Mainz, Germany, to $ 11.1 billion to license a drug. An unusual buying wave has reduced many of the richest people in the world, the size of their assets listed in the stock market periodically to meet the needs of liquidity and ordinary planning for wealth, and the results usually flow to private markets, charity work and other fields. Nevertheless, it is unusual to see that the wealthy people who do this large scope of selling a large number of shares within days, especially in light of the increasing optimism of many of them versus stock markets. Investment companies assigned to the affluent people raise shares in their governors to average, which represent at least the highest level since 2019, according to a poll of the opinions of 317 family offices issued by UPS Group last month. Fewer than 10% of these businesses expected an average of $ 1.1 billion to reduce their shares in the advanced markets over the next five years. On the other hand, some family offices – including Carlos Selim in Mexico, and the Swedish Person Billionaire family – increased in April the number of shares he owned amid the confusion of the market caused by Trump’s commercial policy, to achieve good notebook gains with the recovery of the market. Billionaires direct their investments to other fields that Lorentzon, 56, made the stirring of his wealth, that we have gained from technology to emerging healthcare companies in recent years, including a company founded by his founding partner in “Spotfai” Daniel. The most important investor at Cervantes Capital, a private royal company in Northern European countries, is also accelerating the rate of its expansion plans. On the other hand, Maria del Pino, 69, invests the head of the foundation with the name of her late father, Rafael del Pino, in the past in the shares of US technology companies with major market value, such as “Microsoft”, “Invidia” and “Amazon”. As for the 75 -year -old citrogen, they raised their real estate purchases after picking tremendous profits from the initial investment in ‘Pew N Tech’, which in 2020 had a collaboration with ‘Pfizer’ to develop the first Kofid vaccine to get the approval of the US Food and Medicine Administration.
The rich of Europe is crazy billion dollars from a wave of sale of rare stocks
